Jean-Michel Halfon, head of emerging markets for Pfizer, said: "The eCard is an innovative way to partner with society, patients and governments to help manage chronic diseases at an affordable price." Each patient presents their eCard to a pharmacist to receive an automatic discount on the normal retail price, giving Pfizer information on the drug purchases so it can reimburse the difference to the pharmacist and track patient use directly. By allowing it to offer discounts of up to 50 per cent to patients on the pharmacy price, the move may help increase access to expensive drugs by making them more affordable, while increasing Pfizer's sales.
via ft.com
No comments:
Post a Comment